Novavax (NVAX) Files For UK Authorization of its COVID-19 Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Novavax (NVAX) Files For UK Authorization of its COVID-19 Vaccine

Novavax (NVAX) Files Requesting Provisional Approval of its COVID-19 Vaccine in Australia

October 29, 2021 7:15 AM EDT

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its rolling submission to the Therapeutic Goods Administration (TGA) for provisional approval of its COVID-19 vaccine candidate. The company's application to the TGA marks the first complete application for provisional approval of a protein-based COVID-19 vaccine in Australia.

"This submission brings Novavax significantly closer to delivering doses of the first protein-based COVID-19 vaccine to Australia and, along with this week's filing for... More

Novavax (NVAX) Climbs 13% After Filing For UK Authorization of its COVID-19 Vaccine

October 27, 2021 8:59 AM EDT

Novavax (NASDAQ: NVAX) Climbs 13% After Filing For UK Authorization of its COVID-19 Vaccine

... More